
venVelo
270 W New England Ave, Winter Park, FL, 32789, United States
Overview
venVelo directs the successful entrepreneur through a detailed program with a strict set of guidelines necessary to create effective business operations that lead to successful go-to-market strategies. venVelo is also amassing a mentor network of the best and brightest: successful, proven entrepreneurs who have demonstrated – often many times – they know how to help our portfolio companies do what they need to do to grow. This network of industry experts provides real-world experience. The mentors are hand-picked and matched to the specific needs of our portfolio companies.
- Total investments
- 7
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 5
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Kalogon
Participated · Seed · Sep 2022
Founded in 2019 by CEO Tim Balz, Kalogon develops smart seating solutions focused on seated health, serving people who sit for extended periods across healthcare, aviation and other settings. Its proprietary technology combines real-time sensors, adaptive surfaces and personalized control to restore circulation, protect skin integrity and reduce fatigue. The company manufactures all products in-house and goes to market via clinical partnerships, major DME distributors and direct sales. Kalogon recently raised $5.75M and plans to use the proceeds to expand operations and advance product development. The article notes returning investors among the new round, but does not disclose revenue or user metrics.
- Urban SDK
Participated · Seed · Jan 2022
Urban SDK is a Jacksonville, Florida–based company that has built an AI-powered geospatial “system of action” for public-sector agencies. Its software consolidates disparate municipal workflows—such as citizen complaint management, traffic enforcement, and emergency response—into a single data-driven platform. The company serves more than 300 local government customers across 40 U.S. states, enabling them to make faster, evidence-based decisions while reducing costs to roughly one-tenth of traditional approaches. Urban SDK positions its technology as critical for cities that collectively direct about 70% of their general funds toward public safety and community well-being. By automating decision support, the platform aims to prevent traffic accidents, improve resource allocation, and strengthen community resilience. With fresh growth capital, Urban SDK plans to expand its AI capabilities and broaden its reach to additional cities, agencies, and partners over the coming years.
- Vigilant Biosciences
Participated · Series B · Jul 2016
Vigilant Biosciences develops point-of-care and lab-based products for early detection and intervention of oral cancer. Its OncAlert Oral Cancer product line and OncAlert Labs product line include CE‑marked lab and rapid tests available in select international markets. The company’s patented technology measures soluble CD44 and total protein levels in an oral rinse, biomarkers clinically validated for oral cancer. The OraMark Test is offered as a Laboratory Developed Test (LDT) in the U.S. exclusively through OncAlert Labs, a CLIA‑certified laboratory within the Vigilant family. Led by Founder, Chairman, and CEO Matthew H.J. Kim, the company is based in Ft. Lauderdale, FL. Recent financing will fund expansion of commercial and development efforts and continued research and development of additional products. Vigilant Biosciences is a Miami-based provider of solutions for the early detection and intervention of cancer, initially launching the OncAlert Oral Cancer Risk Assessment System. OncAlert is based on patented technology that detects specific protein markers known to indicate an elevated risk for oral cancer prior to observable visual or physical symptoms. The system comprises a rapid point-of-care test and a lab assay intended for use in every adult, with emphasis on high-risk populations (current and former tobacco users, alcohol consumers, and people with HPV). Both the rapid test and the lab assay were undergoing the CE Mark registration approval process and were expected for release in Q2 2015. The company completed a $5.5M Series B and has raised $7.8M in total to date; it plans to use the funds for CE Mark and U.S. regulatory approval, international product launch and commercialization of OncAlert, and other pipeline products. The company is led by Founder, Chairman and CEO Matthew H.J. Kim. Vigilant Biosciences develops a low-cost, rinse-and-spit oral cancer risk assessment test that produces immediate color changes in the presence of proteins associated with early-onset oral cancer. The company’s initial products are development-stage oral cancer–specific kits intended for broad adult screening, with emphasis on tobacco users, alcohol consumers, and people with HPV. Proceeds from the recent financing will support 510(k) clearance and CE Mark approval efforts and preparation for an international product launch. Vigilant also intends to simultaneously advance other products in its pipeline. The company positions its tests as tools to identify cancers earlier than visual detection, aiming to improve survival rates and reduce healthcare costs. Financially, Vigilant completed an oversubscribed Series A and received additional loan proceeds to fund regulatory and launch activities.
- Stax
Participated · Equity · May 2016
Stax offers an all-in-one payments platform and the industry’s only fully integrated payments API, enabling businesses and software platforms to manage payments, analyze data, and simplify customer experiences. The company says it has powered more than $23 billion in transactions for roughly 22,000 businesses and has grown 500% over the past three years. Stax plans to use new capital to expand product capabilities, enhance customer offerings, grow its team, and expand internationally. It recently acquired automated surcharging platform CardX in November. Stax was founded in 2014 by siblings Suneera Madhani and Sal Rehmetullah and is headquartered in Orlando, Fla. Fattmerchant provides an all-in-one payments and commerce software platform (Omni) and an ISV-focused PayFac integration (Omni Connect) that exposes a single API for bank sponsorship, merchant onboarding, risk management, settlement, and reporting. The company says the new investment will fund increased product innovation and accelerate growth while the founding leadership team — CEO Suneera Madhani and President Sal Rehmetullah — remains in place. Founded in 2014 and based in Orlando, Fattmerchant has expanded its roster of ISV partners and merchant customers since launching Omni Connect. The financing is positioned to help the company deepen its proprietary technology offerings for ISVs and SMBs and commercialize integrated payments as an ancillary revenue stream. In 2020 Fattmerchant received multiple recognitions including Forbes’ Top 50 Fintech, inclusion on the Inc. 5000 and Deloitte’s Technology Fast 500, and was named Private Titans No.1 Fintech Business in Florida; Madhani was named to Fortune’s 40 Under 40. No revenue or user metrics were disclosed in the article. Fattmerchant offers an integrated payments platform combining card-present and card-not-present solutions under one API and a unified dashboard. The platform supplies one merchant account, one subscription, native QuickBooks integration, data analytics and additional business tools across devices. It serves business owners across the United States. Founded in 2014 by Suneera Madhani (CEO) and Sal Rehmetullah (President), the company is based in Atlanta, GA and Orlando, Fla. Fattmerchant closed a $10.5M Series C funding round. The company plans to use the funds to develop its technology platform and create more than 50 jobs over the next 18 months. Fattmerchant provides subscription-based payment technology featuring direct-cost pricing, analytics and omni-channel integrated payments tools for businesses across the nation. The platform aims to improve efficiency and reduce credit card processing costs for customers. The company is co-founded by COO Sal Rehmetullah and CEO Suneera Madhani. Fattmerchant reached $1 billion in transactional volume. It plans to use new funding for continued product and technological developments, marketing and customer acquisition. The company serves businesses of all sizes with tools to save on payment processing. Fattmerchant provides merchant services that offer unlimited credit card processing at direct cost for a flat monthly membership and no contract. Led by founder and CEO Suneera Madhani, the company is based in Orlando, FL and employs about 25 people. The firm plans to build a new suite of technology tools for customers, including an advanced mobile platform. It recently closed a $1.4M funding round and will use the proceeds for continued product and technological developments, marketing and customer acquisition. The raise brings the company’s total funding to $2.25M.
- flexEngage
Led · Series A · Apr 2014
flexReceipts provides an enhanced digital receipts solution that gives retailers a post-sale channel to communicate with customers. Its patent-pending software allows retailers to add social media links, videos and customized offers to digital receipts. The enriched receipts are designed to build customer loyalty by enabling custom video, product recommendations, targeted promotions and monitoring of spending habits and shopping trends. Led by CEO Tomas Diaz, the company plans to use recently raised funds to expand sales and marketing and further develop the solution. The company closed a $1.4M Series A financing to support those efforts. flexReceipts is headquartered in Orlando, Florida.